interleukin 1beta (193-195) has been researched along with Innate Inflammatory Response in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, XM; Leung, WK; Lv, MM; Ren, TH; Seto, WK | 1 |
1 other study(ies) available for interleukin 1beta (193-195) and Innate Inflammatory Response
| Article | Year |
|---|---|
Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
Topics: Adenosine; Colitis, Ulcerative; Colon; Cytokines; Down-Regulation; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; NF-kappa B; Peptide Fragments; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |